A detailed history of Tompkins Financial Corp transactions in Biogen Inc. stock. As of the latest transaction made, Tompkins Financial Corp holds 81 shares of BIIB stock, worth $14,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 81 -0.0%
Holding current value
$14,861
Previous $17,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 20, 2023

BUY
$253.3 - $285.89 $20,517 - $23,157
81 New
81 $20,000
Q4 2020

Feb 05, 2021

BUY
$236.26 - $355.63 $2.28 Million - $3.44 Million
9,668 New
9,668 $3.06 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.